INVESTOR PRESENTATION 2019 Better Data, Better Health WHO ARE WE? - - PowerPoint PPT Presentation

▶
investor presentation 2019
SMART_READER_LITE
LIVE PREVIEW

INVESTOR PRESENTATION 2019 Better Data, Better Health WHO ARE WE? - - PowerPoint PPT Presentation

Jul 20, 2023 554 likes •693 views

TSX-V: AVCR ! OTCQB: AVCRF INVESTOR PRESENTATION 2019 Better Data, Better Health WHO ARE WE? Avricore is a total health innovator capitalizing on technological advancements and consumer health trends, offering consumers, health providers and

slide-1
SLIDE 1

INVESTOR PRESENTATION 2019

Better Data, Better Health

TSX-V: AVCR! OTCQB: AVCRF

slide-2
SLIDE 2

WHO ARE WE?

Avricore is a total health innovator capitalizing on technological advancements and consumer health trends, offering consumers, health providers and life- science companies the ability to take control of both spending and health outcomes. We intend on become the world’s largest health data company and are utilizing point-of-care technologies within community pharmacy to achieve this. www.avricorehealth.com

slide-3
SLIDE 3

QUICK OVERVIEW

! Converted from VANC Pharmaceuticals, a generic drug maker

with 91 generic offerings in 2018 to become Avricore Health Inc.

! Avricore is currently selling Hema-fer, an OTC iron supplement,

to pharmacies across Canada.

! In the transition, Avricore purchased two technologies, the

Avricore Platform (formerly Corozon Platform) and HealthTab.

! The Company’s primary focus today is on developing a network

  • f point-of-care analyzers that utilizes its HealthTab software in

community pharmacy.

slide-4
SLIDE 4

W E L C O M E T O H E A LT H TA B A N D T H E R A S T R M O D E L

The patient driven Rapid Access, Safety Test Reporting system (RASTR)

slide-5
SLIDE 5

2 panels, 21 results Turnkey System

In-store kiosk Lab-accurate analyzer Secure online results

slide-6
SLIDE 6
  • Proven point-of-care screening system,

designed to support pharmacists evolving role.

  • Empowers patients to be proactive about

their health by directly measuring and monitoring key safety tests and biomarkers of chronic disease.

  • Simple, fast, lab-accurate, and requires

just a few drops of blood from a finger stick.

  • Results can be printed in-store or

accessed securely online.

  • Watch short video here and visit our

HealthTab website.

slide-7
SLIDE 7
  • A network of HealthTab systems utilizing the Piccolo

Analyzer in community pharmacies.

  • Running panels on consumers utilizing finger stick

sample, monitoring up to 21 key bio-markers, and/or customizable tests.

  • Allows for API integration for better data flow and

customization.

  • Provides harmonized, real-time data on consumer

health.

R A S T R M O D E L

  • 1. The client purchases the drug or other health product.
  • 2. The pharmacy leases the analyzers at a reasonable cost to become a part of the

network.

  • 3. The drug maker pays to access the network and sponsors test fees for consumer.
slide-8
SLIDE 8

BOARD DIRECTORS

Bob Rai - CEO & director David Hall - Chairman & Director Alan Arnstein! - Director

! BOARD ADVISORS

Ray Chepsiuk – Board Advisor Sherif Guorgui - Board Advisor David Huston- Board Advisor

!

OUR TEAM

Kiki Smith - CFO/Corporate Secretary Hector Bremner – EVP , Strategic Communications/Public Affairs Rodger Seccombe - Head of HealthTab Division

MANAGEMENT

  • Dr. Robert Sindelar - Director

David Farnfield – Director Mark Zhou – Board Advisor Philippe Ungat – Board Advisor

FOR MORE INFORMATION ON OUR TEAM, PLEASE VISIT OUR WEBSITE

slide-9
SLIDE 9

PROJECTIONS

!" !#$%%% !&$%%% !'$%%% !($%%% !)%$%%% !)#$%%% !)&$%%% !)'$%%% !)($%%% !"#$ !"!" !"!# !"!! !"!% !"!& !"!'

())*+,-.+,/0

!"###$%&'(

!"#$%%%& !' !#$%%% !($%%% !)$%%% !*$%%% !+%$%%% !+#$%%% !"#$ !"!" !"!# !"!! !"!% !"!& !"!'

())*+,-.+/012,34

!"###$%&'(

slide-10
SLIDE 10

CAP STRUCTURE

As of September, 2019 Includes shares issued to date as per the Lampyon agreement, the Healthtab Agreement, and the Corozon Agreement (please note: 681,818 of the Corozon shares are subject to a year hold, expiring on May 18, 2019). ** Does not include remaining shares to be issued pursuant to the Lampyon agreement, as these shares are based on calculating the volume weighed average closing share price on the last 5 trading days preceding the date of issue

Common Shares Issued & Outstanding (per Computershare Report - January 7, 2019) ! * Please see note above **Please see note above 52,472,699 Reserved for Stock Options 3,181, 072 Reserved for Warrants @ $0.20 - Expiry Jun 26, 2022 1,791,159 Reserved for Finders Warrants @ $0.20 - Expiry Jun 26, 2022 - All warrants have been exercised.

  • Reserved for Warrants @ $0.20 - Expiry Aug 3, 2022

742,667 Reserved for Warrants @ $0.20 - Expiry Nov 27, 2022 2,872,000 Reserved for Emerald Warrants @ $0.33 (Supply & Distribution Agreement) - Expiry April 15, 2020 3,030,303 Reserved for Warrants @ $0.33 - Expiry Jul 31, 2020 5,416,135 Reserved for Warrants @ $0.15 - Expiry Aug 14, 2021 6,852,400 TOTAL 76,358,435

slide-11
SLIDE 11

OUR PARTNERS

slide-12
SLIDE 12

JOIN US IN REALIZING THIS OPPORTUNITY

Avricore Health is seeking to secure 40 Piccolo Xpress analyzers and expand the RASTR network in the immediate future. The company has no competition in this field, yet. However, as we have demonstrated here, the POCT market is rapidly growing as established health data methods get “smart.” To learn more about how you can invest in the growth of this technology, or partner with us to test your consumers, please contact us at: investor@avricorehealth.com